Related Experiment Videos
Glucocerebrosidase (Gaucher disease)
1Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, California 92037, USA.
Human Mutation
|January 1, 1996
Summary
Gaucher disease is a common glycolipid storage disorder. Type I lacks neurological symptoms, while Types II and III affect the central nervous system.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Gaucher disease is the most common glycolipid storage disorder.
- It involves the accumulation of glucocerebroside in organs like the liver, spleen, and bone marrow.
Purpose of the Study:
- To differentiate the clinical manifestations of Gaucher disease types.
- To highlight the key diagnostic features of each subtype.
Main Methods:
- Clinical case review.
- Genetic analysis.
- Biochemical assays.
Main Results:
- Type I Gaucher disease presents with organomegaly and bone lesions but no neurological involvement.
- Types II and III involve central nervous system (CNS) impairment, differing in age of onset and severity.
Conclusions:
- Gaucher disease subtypes exhibit distinct clinical phenotypes.
- Neurological involvement is a critical differentiator between Type I and Types II/III.